Aclaris Therapeutics, Inc. (ACRS)
5.65
+0.33
(+6.20%)
USD |
NASDAQ |
Sep 14, 16:00
5.65
0.00 (0.00%)
After-Hours: 16:59
Aclaris Therapeutics Price : 5.65 for Sept. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 5.50 | 5.595 | 5.17 | 5.32 | 3.278M |
| Sep 10, 2026 | 5.55 | 5.555 | 5.385 | 5.505 | 2.211M |
| Sep 09, 2026 | 6.075 | 6.075 | 5.41 | 5.56 | 3.679M |
| Sep 08, 2026 | 6.08 | 6.145 | 5.915 | 6.06 | 3.061M |
| Sep 04, 2026 | 5.965 | 6.195 | 5.87 | 6.17 | 1.747M |
| Sep 03, 2026 | 6.24 | 6.27 | 5.895 | 5.95 | 1.392M |
| Sep 02, 2026 | 6.09 | 6.24 | 5.875 | 6.18 | 1.550M |
| Sep 01, 2026 | 6.09 | 6.24 | 5.95 | 6.02 | 1.487M |
| Aug 31, 2026 | 5.97 | 6.06 | 5.845 | 6.05 | 1.633M |
| Aug 28, 2026 | 6.10 | 6.18 | 5.95 | 6.01 | 1.221M |
| Aug 27, 2026 | 6.15 | 6.305 | 6.12 | 6.16 | 1.409M |
| Aug 26, 2026 | 6.53 | 6.53 | 6.07 | 6.19 | 1.736M |
| Aug 25, 2026 | 6.36 | 6.600 | 6.15 | 6.535 | 3.353M |
| Aug 24, 2026 | 6.35 | 6.40 | 6.02 | 6.31 | 1.273M |
| Aug 21, 2026 | 6.36 | 6.50 | 6.29 | 6.41 | 2.208M |
| Aug 20, 2026 | 6.35 | 6.46 | 6.17 | 6.33 | 1.515M |
| Aug 19, 2026 | 6.40 | 6.449 | 6.20 | 6.44 | 2.065M |
| Aug 18, 2026 | 5.88 | 6.315 | 5.854 | 6.305 | 2.013M |
| Aug 17, 2026 | 5.72 | 5.955 | 5.685 | 5.92 | 1.086M |
| Aug 14, 2026 | 5.82 | 5.855 | 5.64 | 5.78 | 666269.0 |
| Aug 13, 2026 | 5.90 | 6.055 | 5.812 | 5.86 | 1.066M |
| Aug 12, 2026 | 5.94 | 5.97 | 5.84 | 5.84 | 937109.0 |
| Aug 11, 2026 | 5.90 | 5.935 | 5.80 | 5.92 | 1.210M |
| Aug 10, 2026 | 5.92 | 5.99 | 5.67 | 5.90 | 1.594M |
| Aug 07, 2026 | 6.08 | 6.23 | 5.65 | 5.91 | 2.388M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 111.69 |
| Nektar Therapeutics | 68.43 |
| Xeris Biopharma Holdings, Inc. | 7.58 |
| Crinetics Pharmaceuticals, Inc. (DELISTED) | 84.95 |
| Alumis, Inc. | 9.20 |
Price Related Metrics
| PS Ratio | 88.82 |
| Price to Book Value | 6.341 |
| Earnings Yield | -10.36% |
| Market Cap | 790.01M |